|
|
Prepublished online as a Blood First Edition Paper on September 12, 2002; DOI 10.1182/blood-2002-05-1549.
Previous Article | Table of Contents | Next Article 
Blood, 15 January 2003, Vol. 101, No. 2, pp. 498-507
HEMATOPOIESIS
Levels of phospho-Smad2/3 are sensors of the interplay between
effects of TGF- and retinoic acid on monocytic and granulocytic
differentiation of HL-60 cells
Zhouhong Cao,
Kathleen C. Flanders,
Daniel Bertolette,
Lyudmila A. Lyakh,
Jens U. Wurthner,
W. Tony Parks,
John J. Letterio,
Francis W. Ruscetti, and
Anita B. Roberts
From the Laboratory of Cell Regulation and
Carcinogenesis, National Cancer Institute, Bethesda, MD, and the Basic
Research Laboratory, National Cancer Institute (NCI)-Frederick,
Frederick, MD.
We have investigated the role of Smad family proteins, known to be
important cytoplasmic mediators of signals from the transforming growth
factor- (TGF- ) receptor serine/threonine kinases, in TGF- -dependent differentiation of hematopoietic cells, using as a
model the human promyelocytic leukemia cell line, HL-60. TGF- -dependent differentiation of these cells to monocytes, but not
retinoic acid-dependent differentiation to granulocytes, was accompanied by rapid phosphorylation and nuclear translocation of Smad2
and Smad3. Vitamin D3 also induced phosphorylation of Smad2/3 and monocytic differentiation; however the effects were indirect, dependent on its ability to induce expression of TGF- 1. Simultaneous treatment of these cells with TGF- 1 and
all-trans-retinoic acid (ATRA), which leads to
almost equal numbers of granulocytes and monocytes, significantly
reduced the level of phospho-Smad2/3 and its nuclear accumulation,
compared with that in cells treated with TGF- 1 alone. TGF- 1 and
ATRA activate P42/44 mitogen-activated protein (MAP)
kinase with nearly identical kinetics, ruling out its involvement in
these effects on Smad phosphorylation. Addition of the
inhibitor-of-protein serine/threonine phosphatases, okadaic acid,
blocks the ATRA-mediated reduction in TGF- -induced phospho-Smad2 and shifts the differentiation toward monocytic end points. In HL-60R
mutant cells, which harbor a defective retinoic acid receptor- (RAR- ), ATRA is unable to reduce levels of
TGF- -induced phospho-Smad2/3, coincident with its inability to
differentiate these cells along granulocytic pathways. Together, these
data suggest a new level of cross-talk between ATRA and TGF- ,
whereby a putative RAR- -dependent phosphatase activity limits the
levels of phospho-Smad2/3 induced by TGF- , ultimately reducing the
levels of nuclear Smad complexes mediating the TGF- -dependent
differentiation of the cells to monocytic end points.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Kawajiri, M. Yashiro, O. Shinto, K. Nakamura, M. Tendo, S. Takemura, M. Node, Y. Hamashima, T. Kajimoto, T. Sawada, et al.
A Novel Transforming Growth Factor {beta} Receptor Kinase Inhibitor, A-77, Prevents the Peritoneal Dissemination of Scirrhous Gastric Carcinoma
Clin. Cancer Res.,
May 1, 2008;
14(9):
2850 - 2860.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ji, H. J. Lee, C. Goodman, M. Uskokovic, K. Liby, M. Sporn, and N. Suh
The synthetic triterpenoid CDDO-imidazolide induces monocytic differentiation by activating the Smad and ERK signaling pathways in HL60 leukemia cells.
Mol. Cancer Ther.,
June 1, 2006;
5(6):
1452 - 1458.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. J. Lee, A. Wislocki, C. Goodman, Y. Ji, R. Ge, H. Maehr, M. Uskokovic, M. Reiss, and N. Suh
A Novel Vitamin D Derivative Activates Bone Morphogenetic Protein Signaling in MCF10 Breast Epithelial Cells
Mol. Pharmacol.,
June 1, 2006;
69(6):
1840 - 1848.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Urahama, M. Ito, A. Sada, K. Yakushijin, K. Yamamoto, A. Okamura, K. Minagawa, A. Hato, K. Chihara, R. G. Roeder, et al.
The role of transcriptional coactivator TRAP220 in myelomonocytic differentiation
Genes Cells,
December 1, 2005;
10(12):
1127 - 1137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Lyakh, M. Sanford, S. Chekol, H. A. Young, and A. B. Roberts
TGF-{beta} and Vitamin D3 Utilize Distinct Pathways to Suppress IL-12 Production and Modulate Rapid Differentiation of Human Monocytes into CD83+ Dendritic Cells
J. Immunol.,
February 15, 2005;
174(4):
2061 - 2070.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Birchenall-Roberts, T. Fu, O.-s. Bang, M. Dambach, J. H. Resau, C. L. Sadowski, D. C. Bertolette, H.-J. Lee, S.-J. Kim, and F. W. Ruscetti
Tuberous Sclerosis Complex 2 Gene Product Interacts with Human SMAD Proteins: A MOLECULAR LINK OF TWO TUMOR SUPPRESSOR PATHWAYS
J. Biol. Chem.,
June 11, 2004;
279(24):
25605 - 25613.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Duan and M. Horwitz
Targets of the transcriptional repressor oncoprotein Gfi-1
PNAS,
May 13, 2003;
100(10):
5932 - 5937.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |